- Generic name
- Ondansetron
- Strength
- 80 mg/100 ml
- Dosage form
- Solution
- Manufactured by
- Albion Laboratories Ltd.
Emofast Oral Solution Solution
About Emofast Oral Solution 80 mg/100 ml
Emofast Oral Solution is a solution from Albion Laboratories Ltd., with the generic name Ondansetron. Emofast Oral Solution 80 mg/100 ml solution is used to prevent nausea and vomiting linked to cancer chemotherapy and radiotherapy.
There are 74 brands of Ondansetron listed in Bangladesh. The lowest listed price is Periset 16 mg Suppository at ৳ 1 per unit.
What is Emofast Oral Solution 80 mg/100 ml?
Emofast Oral Solution 80 mg/100 ml is a solution product of Albion Laboratories Ltd. that contains Ondansetron. Emofast Oral Solution solution is a medicine that contains Ondansetron, which belongs to a group called anti-emetics. It works by blocking a natural substance in the body that triggers the vomiting reflex, helping to control nausea and vomiting. Always follow the doctor's instructions and ask a pharmacist if anything is unclear.
Uses of Emofast Oral Solution
Emofast Oral Solution 80 mg/100 ml solution is used to prevent nausea and vomiting linked to cancer chemotherapy and radiotherapy. It is not a general nausea medicine for all causes; it is meant for these specific situations. The doctor will decide if it is suitable and how it should be used.
How to use Emofast Oral Solution
It is not for self-administration at home. Complete the course exactly as prescribed. Do not change the dose or stop early without asking your doctor.
Side effects of Emofast Oral Solution
Rarely, serious allergic reactions, breathing problems, or chest pain have been reported. Some people may experience side effects while taking Emofast Oral Solution solution. Tell your doctor if you experience any side effect that bothers you or does not go away. Tell your doctor if you notice any side effect, especially one that worries you.
Safety and precautions
Ondansetron was not mutagenic in standard tests for mutagenicity. Contraindicated in patients known to have hypersensitivity to the drug or any of its components. There are, however, no adequate and well-controlled studies in pregna Tell your doctor about all the other medicines you take.
Frequently asked questions
Why is Emofast Oral Solution prescribed?
Emofast Oral Solution 80 mg/100 ml solution is used to prevent nausea and vomiting linked to cancer chemotherapy and radiotherapy. It is not a general nausea medicine for all causes; it is meant for these specific situations.
How do I use Emofast Oral Solution correctly?
It is not for self-administration at home. Complete the course exactly as prescribed.
What should I watch for while using Emofast Oral Solution?
Rarely, serious allergic reactions, breathing problems, or chest pain have been reported. Some people may experience side effects while taking Emofast Oral Solution solution.
Who should be careful with Emofast Oral Solution?
Ondansetron was not mutagenic in standard tests for mutagenicity. Contraindicated in patients known to have hypersensitivity to the drug or any of its components.
Indications
- Prevention of nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy.
- Prevention and treatment of post-operative nausea and vomiting.
- Prevention of radiotherapy-induced nausea and vomiting.
Pharmacology
Dosage & Administration
Adults, Pediatric patients (6 months to 18 years):
- 8 mg tablet/orodispersible tablet: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose.
- 4 mg orodispersible tablet: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose.
- Injection: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose, infused intravenously over 15 minutes.
Adults:
- 8 mg tablet/orodispersible tablet: Initial Dose: 8 mg orally 1 to 2 hours before radiotherapy. Post Radiotherapy: 8 mg orally every 8 hours for up to 5 days after a course of treatment.
- 4 mg orodispersible tablet: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose.
- Injection: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose, infused intravenously over 15 minutes.
Adults:
- 8 mg tablet/orodispersible tablet: 16 mg given as two 8 mg tablets
- 4 mg orodispersible tablet: 16 mg
- Injection: 4 mg
Pediatrics (40 kg): Injection: 0.1 mg/kg
Chemotherapy-induced Nausea and Vomiting-
Adults/Geriatric/Child of 12 years or over:
- Highly emetogenic cancer chemotherapy: 30 ml (24 mg) Ondansetron Oral Solution administered 30 minutes before start of emetogenic chemotherapy.
- Moderate emetogenic cancer chemotherapy: 10 ml (8 mg) Ondansetron Oral Solution administered 30 minutes before start of emetogenic chemotherapy. A further 10 ml dose should be administered after 8 hours of the first dose. One 10 ml dose should be administered twice a day (every 12 hours) for 1-2 days after completion of chemotherapy.
Oral solution:
Radiotherapy induced Nausea and Vomiting (Adults/Geriatric/Child of 12 years or over):- The recommended oral dosage: 10 ml (8 mg) Ondansetron Oral Solution 3 times daily.
- For total body irradiation: 10 ml (8-mg) Ondansetron Oral Solution should be administered 1 to 2 hours before each fraction of radiotherapy administered each day.
- For single high-dose fraction radiotherapy to the abdomen: one 10 ml Ondansetron Oral Solution should be administered 1 to 2 hours before radiotherapy, with subsequent doses every 8 hours after the first dose for 1 to 2 days after completion of radiotherapy.
- For daily fractionated radiotherapy to the abdomen: 10 ml (8-mg) Ondansetron Oral Solution should be administered 1 to 2 hours before radiotherapy, with subsequent doses every 8 hours after the first dose for each day radiotherapy is given.
- 20 ml (16 mg) Ondansetron Oral Solution 1 hour before induction of anesthesia
Oral Soluble Film:
Prevention of nausea and vomiting associated with highly emetogenic cancer chemotherapy:- Adult oral dose: 24 mg given successively as three 8 mg films 30 minutes before the start of chemotherapy.
- Adults and pediatric patients 12 years of age and older: One 8 mg film 30 minutes before chemotherapy followed by an 8 mg dose 8 hours later. Administer one 8 mg film twice a day (every 12 hours) for 1 to 2 days after completion of chemotherapy.
- Pediatric patients 4 through 11 years of age: One 4 mg film three times a day. Administer the first dose 30 minutes before chemotherapy, with subsequent doses 4 and 8 hours later. Administer one 4 mg film three times a day (every 8 hours) for 1 to 2 days after completion of chemotherapy.
- Prevention of nausea and vomiting associated with radiotherapy: The adult dosage is one 8 mg film three times a day.
- Postoperative nausea and vomiting: The adult dose is 16 mg given successively as two 8 mg films 1 hour before anesthesia.
Interaction
Contraindications
Side Effects
Pregnancy & Lactation
Reproduction studies have been performed in pregnant rats and rabbits at daily oral doses up to 15 and 30 mg/kg per day, respectively, and have revealed no evidence of impaired fertility or harm to the fetus due to Ondansetron. There are, however, no adequate and well-controlled studies in pregnant women. Ondansetron is excreted in the breast milk of rats. So caution should be exercised when Ondansetron is administered to a nursing women.
Precautions & Warnings
Storage Conditions
Alternative brands of Ondansetron
Other brands with the same generic name, cheapest first.
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.